Literature DB >> 16162500

Features of the catalytic domains and C termini of the MAPK signal-integrating kinases Mnk1 and Mnk2 determine their differing activities and regulatory properties.

Josep Lluis Parra1, Maria Buxadé, Christopher G Proud.   

Abstract

The MAPK signal-integrating kinases Mnk1 and Mnk2 are closely related but show marked differences in their basal activities and regulation. Both possess, within their C termini, motifs for binding to MAPKs, although these differ between Mnk1 and Mnk2. Mnk2 shows much higher activity in unstimulated cells than Mnk1, whose activity is greatly increased, e.g. by stimulation of the MEK/ERK pathway. Such increases are sensitive to blockade of that pathway, whereas the activation state of Mnk2 is relatively insensitive to inhibition of upstream signaling. Here we have studied the roles of features in their catalytic domains and C termini in determining their regulatory properties and basal activities. Mnk2 can bind to phosphorylated, active ERK, whereas Mnk1 cannot. Such binding apparently protects ERK against dephosphorylation and inactivation. The high basal activity of Mnk2 and its binding to (phospho)ERK requires features both of the catalytic domain and of the C terminus. For example, within the catalytic region an aspartate in Mnk2 plays a key role. Mutation to alanine inactivates Mnk2. In the C terminus, features within the MAPK-binding motif and to either side of it, including potential phosphorylation sites, affect MAPK binding and activity. The association of Mnks with the scaffold protein eukaryotic initiation factor 4G is negatively modulated by Mnk activity. These data indicate that multiple features determine the activities of the Mnks and thus impact on their ability to phosphorylate physiological substrates such as eukaryotic initiation factor 4E.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16162500     DOI: 10.1074/jbc.M508356200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  MNK kinases facilitate c-myc IRES activity in rapamycin-treated multiple myeloma cells.

Authors:  Y Shi; P Frost; B Hoang; Y Yang; R Fukunaga; J Gera; A Lichtenstein
Journal:  Oncogene       Date:  2012-02-27       Impact factor: 9.867

2.  Roles of mitogen-activated protein kinase signal-integrating kinases 1 and 2 in oxidant-mediated eIF4E phosphorylation.

Authors:  Jeffrey S Shenberger; Lianqin Zhang; Mariah K Hughlock; Takeshi Ueda; Rie Watanabe-Fukunaga; Rikiro Fukunaga
Journal:  Int J Biochem Cell Biol       Date:  2007-05-10       Impact factor: 5.085

3.  Mitogen-activated protein kinases interacting kinases are autoinhibited by a reprogrammed activation segment.

Authors:  Ralf Jauch; Min-Kyu Cho; Stefan Jäkel; Catharina Netter; Kay Schreiter; Babette Aicher; Markus Zweckstetter; Herbert Jäckle; Markus C Wahl
Journal:  EMBO J       Date:  2006-08-17       Impact factor: 11.598

4.  A novel inhibitor stabilizes the inactive conformation of MAPK-interacting kinase 1.

Authors:  Yumi Matsui; Isao Yasumatsu; Ken Ichi Yoshida; Shin Iimura; Yutaka Ikeno; Takako Nawano; Hajime Fukano; Osamu Ubukata; Hiroyuki Hanzawa; Fumie Tanzawa; Takeshi Isoyama
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2018-02-26       Impact factor: 1.056

5.  Exploring aigialomycin d and its analogues as protein kinase inhibitors for cancer targets.

Authors:  Jin Xu; Anqi Chen; Mei-Lin Go; Kassoum Nacro; Boping Liu; Christina L L Chai
Journal:  ACS Med Chem Lett       Date:  2011-07-17       Impact factor: 4.345

Review 6.  Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases.

Authors:  Marie Cargnello; Philippe P Roux
Journal:  Microbiol Mol Biol Rev       Date:  2011-03       Impact factor: 11.056

7.  Pseudorabies virus tegument protein Us2 recruits the mitogen-activated protein kinase extracellular-regulated kinase (ERK) to membranes through interaction with the ERK common docking domain.

Authors:  Ming-Hsi Kang; Bruce W Banfield
Journal:  J Virol       Date:  2010-06-16       Impact factor: 5.103

8.  Mnk Kinases in Cytokine Signaling and Regulation of Cytokine Responses.

Authors:  Sonali Joshi; Leonidas C Platanias
Journal:  Biomol Concepts       Date:  2012-04

Review 9.  Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia.

Authors:  Ewa M Kosciuczuk; Diana Saleiro; Leonidas C Platanias
Journal:  Cytokine       Date:  2016-04-16       Impact factor: 3.861

10.  Etanercept as a TNF-alpha inhibitor depresses experimental retinal neovascularization.

Authors:  Yixuan Yao; Yujuan Cai; Ailing Sui; Yiyun Yao; Ting Su; Yanji Zhu; Bing Xie; Xi Shen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-10-12       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.